Overview Request Sample Pages Request Customization Download PDF
You are viewing: China Pharmaceutical Excipients Market analysis

The China Pharmaceutical Excipients Market was valued at $926.8 Million in 2025 and projected to reach to $1366.7 Million by 2030, representing a compound annual growth rate of 8.1%. China's pharmaceutical excipients market is poised for substantial growth, expanding from USD 926.8 million in 2025 to USD 1,366.7 million by 2030.

China Pharmaceutical Excipients Market Trends and Insights

  • This expansion reflects China's position as a global pharmaceutical manufacturing hub and the rising demand for high-quality excipients driven by increased domestic drug production and regulatory modernization.
  • China's market growth rate of 8.1% CAGR significantly outpaces the global average of 6.1%, underscoring the country's accelerating pharmaceutical sector development. The growth trajectory in China is fueled by several factors including increased investment in pharmaceutical infrastructure, stricter quality standards aligned with international guidelines, and growing biopharmaceutical innovation.
  • China's excipient manufacturers are expanding capacity and upgrading production capabilities to meet both domestic and export demand.
  • Between 2025 and 2030, China is expected to capture an increasingly larger share of Asia Pacific pharmaceutical excipient consumption, driven by cost competitiveness and manufacturing scale..

Key Market Statistics

  • CAGR (2025-2030) 8.1% CAGR
  • Market Size, 2025 ~USD 926.8 Million
  • Forecast, 2030 ~USD 1366.7 Million
  • Country China

China Pharmaceutical Excipients Market Overview

Manufacturing Hub Dominance :

China's position as the world's largest pharmaceutical manufacturer drives sustained demand for excipients, with domestic production capacity expanding to meet both local and export requirements.

Regulatory Modernization Impact :

Implementation of stricter pharmaceutical standards and alignment with international quality requirements has increased demand for premium-grade excipients that meet global compliance benchmarks.

Rapid Market Expansion :

The market is growing at 8.1% CAGR, outpacing the global rate of 6.1%, reflecting China's accelerating pharmaceutical innovation and increased investment in drug development infrastructure.

Rising Domestic Consumption :

Growing healthcare expenditure and expanding pharmaceutical consumption among China's aging population are driving increased excipient requirements for domestic drug formulation and manufacturing.

China Pharmaceutical Excipients Market Dynamics

  • This trajectory is underpinned by China's role as a global pharmaceutical manufacturing powerhouse, coupled with domestic regulatory enhancements that mandate higher-quality excipient standards.
  • The market benefits from increased R&D investments in innovative drug formulations and the government's push toward pharmaceutical self-sufficiency. Key growth drivers include rising healthcare spending, an aging demographic requiring more medications, and the expansion of biopharmaceutical manufacturing.
  • Additionally, China's commitment to reducing import dependency for critical pharmaceutical inputs is spurring domestic excipient production capacity.
  • Market players should anticipate increased competition, consolidation among suppliers, and growing demand for specialized excipients used in advanced drug delivery systems and biologics manufacturing..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • SANOFI
  • NOVARTIS
  • Pfizer Inc.

    Key Takeaways

    • China's pharmaceutical excipients market will grow from USD 926.8 million in 2025 to USD 1,366.7 million in 2030, representing an 8.1% CAGR.
    • China's market growth rate of 8.1% CAGR exceeds the global average of 6.1%, positioning China as a key growth driver for the Asia Pacific region.
    • China's expanding pharmaceutical manufacturing base and regulatory alignment with international standards are driving increased demand for high-quality excipients.
    • China's cost-competitive production and manufacturing scale position the country as a critical supplier for both domestic and international pharmaceutical markets.

    Pharmaceutical Excipients Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment OTHER FUNCTIONALITIES (Functionality)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.1% from 2025 to 2030
    Largest Segment ORGANIC CHEMICALS (Product)
    Market Size Base Year (Billions) ~USD 11.05 (2025)
    Revenue Forecast (Billions) ~USD 14.86 (2030)
    Segments Covered Product, Type, Functionality Application, Functionality, Formulation

    China Pharmaceutical Excipients Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product

    • Inorganic Chemicals
    • Organic Chemicals
    • Other Chemicals

    By Type

    • Acrylic Polymers
    • Actual Sugars
    • Artificial Sweeteners
    • Calcium Carbonate
    • Calcium Phosphate
    • Calcium Sulphate
    • Capsules
    • Carbohydrates
    • Cellulose
    • Cellulose Esters
    • Cellulose Ethers
    • Cmc & Croscarmellose Sodium
    • Converted Starch
    • Dextrose
    • Dextrose (D-Glucose)
    • Dried Starch
    • Fatty Alcohols
    • Glycerin
    • Glycols
    • Halites
    • Hard-Gelatin Capsules
    • Lactose
    • Liquid Formulations
    • Mannitol
    • Metal Oxides
    • Metal Stearates
    • Microcrystalline Cellulose
    • Mineral Hydrocarbons
    • Mineral Oils
    • Mineral Stearates
    • Mineral Waxes
    • Modified Starch
    • Oleochemicals
    • Other Inorganic Chemicals
    • Other Oleochemicals
    • Other Oral Formulations
    • Other Organic Chemicals
    • Other Petrochemical Excipients
    • Other Sugar Alcohols
    • Petrochemicals
    • Petrolatum
    • Polyethylene Glycol
    • Polyethylene Glycol (Peg)
    • Povidones
    • Propylene Glycol
    • Propylene Glycol (Pg)
    • Proteins
    • Soft-Gelatin Capsules
    • Sorbitol
    • Starch
    • Sucrose
    • Sugar Alcohols
    • Sugars
    • Tablets

    By Functionality Application

    • Modified-Release
    • Other Applications
    • Solubility & Bioavailability Enhancement
    • Stabilizer
    • Stabilizers
    • Taste Masking

    By Functionality

    • Binders
    • Coating Agents
    • Colorants
    • Disintegrants
    • Emulsifiers & Solubilizers
    • Emulsifying Agents
    • Fillers & Diluents
    • Flavoring Agents & Sweeteners
    • Flavouring Agents & Sweeteners
    • Lubricants & Glidants
    • Other Functionalities
    • Preservatives
    • Suspending & Viscosity Agents

    By Formulation

    • Oral Formulations
    • Other Formulations
    • Parenteral Formulations
    • Topical Formulations

    Target Audience

    • Pharmaceutical Manufacturers : Chinese and multinational drug manufacturers operating in China need market data to optimize excipient sourcing, negotiate supplier contracts, and plan production capacity expansions.
    • Excipient Suppliers & Distributors : Domestic and international excipient producers require detailed market insights to identify growth segments, assess competitive threats, and develop targeted sales strategies for the Chinese market.
    • Contract Manufacturing Organizations (CMOs) : CMOs and contract development manufacturers in China need market forecasts to anticipate excipient demand from clients, optimize inventory management, and plan facility investments.
    • Investment & Private Equity Firms : Investors evaluating pharmaceutical supply chain opportunities in China require validated market data, growth projections, and competitive analysis to support M&A and investment decisions.
    • Regulatory & Quality Assurance Teams : Pharmaceutical quality professionals need China-specific regulatory trends and excipient standards data to ensure compliance, validate supplier qualifications, and maintain product quality standards.

    Key Companies in the China Pharmaceutical Excipients Market

    CompanyHQOwnershipStrongest segments
    PATHEON INCNetherlandsPrivate CompanyDrug product services (finished dosage manufacturing, packaging, lifecycle management),Pharmaceutical development services (formulation, analytical, clinical trial supply),Drug substance services (API and biologics substance production),
    BIOMERIEUX S.A.FrancePublic CompanyClinical microbiology (culture media, VITEK, ID/AST, ETEST, API),Syndromic and molecular diagnostics (BIOFIRE, SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    ALLERGAN PLCIrelandPrivate CompanyMedical aesthetics & dermatology,Eye care,Neuroscience & CNS,
    FMC CORPORATIONUnited StatesPublic CompanyInsecticides,Herbicides,Fungicides,
    TOKUYAMA CORPORATIONJapanPublic CompanyChemicals Products (chlor-alkali, PVC, solvents, basic chemicals),Cement and Building Materials,Electronics & Advanced Materials,
    HELM AGGermanyPrivate CompanyBasic chemicals, acids and lyes,Plastics and polyurethanes,Crop protection and fertilizers,
    INTERNATIONAL FLAVORS & FRAGRANCES INC.United StatesPublic CompanyTaste,Food Ingredients,Health & Biosciences,
    ADMUnited StatesPublic CompanyAg Services and Oilseeds,Carbohydrate Solutions,Nutrition (human and animal),
    BASF SEGermanyPublic CompanyChemicals,Materials,Industrial Solutions,
    EVONIKGermanyPublic CompanyAdvanced Technologies,Custom Solutions,Infrastructure,
    ASHLANDUnited StatesPublic CompanyLife Sciences,Personal Care,Specialty Additives,
    KERRY GROUP PLCIrelandPublic CompanyTaste solutions (dairy/dairy-free, savoury, smoke & grill, sweet, modulations),Nutrition solutions (enzymes, proteins, lipids, fibre, wellness, dairy ingredients),Functional ingredients, food & beverage solutions,
    MERCKUnited StatesPublic CompanyOncology (Keytruda, Keytruda Qlex, Welireg, Lynparza collaboration, deruxtecan ADCs),Vaccines (Gardasil, pediatric and adult vaccines including Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23),Hospital & Specialty (Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/Verquvo, Ohtuvayre),
    ASSOCIATED BRITISH FOODS PLCUnited KingdomPublic CompanyRetail (Primark/Penneys),Grocery,Ingredients,
    WACKER CHEMIE AGGermanyPublic CompanySilicones,Polymers,Polysilicon,
    AIR LIQUIDEFrancePublic CompanyLarge Industries (oxygen, nitrogen, argon, hydrogen, CO, cogeneration),Industrial Merchant (bulk, cylinder, hardgoods, services),Healthcare (medical gases, home healthcare, equipment, specialty ingredients),
    DOWUnited StatesPublic CompanyPackaging & Specialty Plastics,Industrial Intermediates & Infrastructure,Performance Materials & Coatings,

    PATHEON INC

    Patheon Inc is a private pharmaceutical manufacturing company based in the Netherlands with 9,100 employees, providing contract development and manufacturing services.

    BIOMERIEUX S.A.

    bioMérieux S.A. is a French public company founded in 1963 with 14,894 employees, specializing in in vitro diagnostics and microbiology testing solutions.

    ALLERGAN PLC

    Allergan PLC is a private pharmaceutical company headquartered in Ireland, founded in 1983, with 17,400 employees focused on specialty therapeutics and medical aesthetics.

    FMC CORPORATION

    FMC Corporation is a U.S. public company founded in 1883 with 5,500 employees, operating in agricultural sciences, health and nutrition, and lithium production.

    TOKUYAMA CORPORATION

    Tokuyama Corporation is a Japanese public company founded in 1918 with 6,390 employees, producing specialty chemicals, semiconductors, and dental materials.

    HELM AG

    Helm AG is a German private chemical distribution and manufacturing company founded in 1900 with 1,430 employees, serving pharmaceutical and industrial sectors.

    INTERNATIONAL FLAVORS & FRAGRANCES INC.

    International Flavors & Fragrances Inc. is a U.S. public company founded in 1909 with 21,500 employees, creating flavors, fragrances, and specialty ingredients for consumer products.

    ADM

    ADM (Archer Daniels Midland) is a U.S. public company founded in 1902 with 41,147 employees, operating in agricultural processing, food ingredients, and nutrition.

    BASF SE

    BASF SE is a German public company founded in 1865 with 106,428 employees, operating as a global leader in chemicals, plastics, performance products, and agricultural solutions.

    EVONIK

    Evonik is a German public company founded in 1847 with 30,643 employees, specializing in specialty chemicals, advanced materials, and performance products.

    ASHLAND

    Ashland is a U.S. public company founded in 1924 with 2,900 employees, providing specialty chemicals and additives for coatings, adhesives, and other industrial applications.

    KERRY GROUP PLC

    Kerry Group PLC is an Irish public company founded in 1972 with 19,284 employees, specializing in food ingredients, flavors, and consumer nutrition solutions.

    MERCK

    Merck is a U.S. public pharmaceutical company founded in 1891 with 74,000 employees, developing and manufacturing prescription medicines, vaccines, and healthcare products.

    ASSOCIATED BRITISH FOODS PLC

    Associated British Foods PLC is a British public company founded in 1934 with 138,000 employees, operating in retail, food, ingredients, and logistics.

    WACKER CHEMIE AG

    Wacker Chemie AG is a German public company founded in 1914 with 16,196 employees, producing specialty chemicals, silicones, and polymers for diverse industries.

    AIR LIQUIDE

    Air Liquide is a French public company founded in 1902 with 63,126 employees, providing industrial gases, welding equipment, and healthcare solutions globally.

    DOW

    Dow is a U.S. public company founded in 1897 with 34,600 employees, manufacturing plastics, chemicals, and agricultural products for industrial and consumer markets.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise valuation data for China's excipients market (USD 926.8M in 2025) with 5-year forecasts, enabling accurate budget allocation and investment decisions specific to this high-growth region.
    • Competitive Landscape Intelligence : Understand China-specific market dynamics, local supplier ecosystems, and competitive positioning to identify partnership opportunities and market entry strategies in the world's largest pharmaceutical manufacturing hub.
    • Regulatory & Compliance Insights : Access detailed analysis of China's evolving pharmaceutical standards and quality requirements driving excipient demand, ensuring your products and strategies align with local regulatory expectations.
    • Demand Forecasting Accuracy : Leverage China-specific growth projections (8.1% CAGR) and market segmentation data to forecast demand for specific excipient types, optimize supply chain planning, and capture emerging opportunities.
    • Strategic Market Positioning : Identify high-potential customer segments within China's pharmaceutical industry, including domestic manufacturers, biopharmaceutical firms, and contract manufacturers seeking quality excipient suppliers.

    Frequently asked questions

    What is the current size of China's pharmaceutical excipients market?

    China's pharmaceutical excipients market is valued at USD 926.8 million in 2025 and is projected to reach USD 1,366.7 million by 2030.

    What is the expected growth rate for China's pharmaceutical excipients market?

    China's pharmaceutical excipients market is expected to grow at a CAGR of 8.1% from 2025 to 2030, outpacing the global average of 6.1%.

    Why is China's pharmaceutical excipients market growing faster than the global average?

    China's faster growth is driven by its position as a global pharmaceutical manufacturing hub, increased domestic drug production, regulatory modernization, and expanding biopharmaceutical innovation.

    What factors are driving demand for excipients in China?

    Key drivers include increased pharmaceutical manufacturing capacity, stricter quality standards aligned with international guidelines, growing biopharmaceutical development, and rising domestic healthcare demand.

    How does China's pharmaceutical excipients market compare to other Asia Pacific countries?

    China represents a significant portion of the Asia Pacific pharmaceutical excipients market due to its manufacturing scale, cost competitiveness, and growing domestic pharmaceutical sector.

    RESEARCH METHODOLOGY

    This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global pharmaceutical excipients market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the pharmaceutical excipients market. The secondary sources used for this study Source: International Pharmaceutical Excipient Council Federation (IPEC), European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceutical Research and Manufacturers of America (PhRMA), Parenteral Drug Association (PDA), International Pharmaceutical Excipients Council (IPEC), International Journal of Production Research (IJPR), Generics and Biosimilars Initiative (GaBI), International Trade Centre, World Journal of Pharmaceutical Sciences, Distributor Presentations, Annual Reports, SEC Filings, Investor Presentations, Press Releases, Conferences, Journals, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    Following an initial assessment of the global Pharmaceutical Excipients market landscape through secondary research, comprehensive primary research was undertaken. This involved conducting in-depth interviews with market experts from the demand side, including stakeholders from pharmaceutical and biotechnology firms, CROs, CMOs, and academic and research institutions. Additionally, interviews were held with key supply-side participants, such as C-suite and senior executives, product managers, and marketing and sales leaders from prominent manufacturers, distributors, and channel partners. The research covered six major geographical regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% of the primary interviews were conducted with supply-side participants, while 30% involved demand-side experts. Data collection methods included structured questionnaires, email correspondence, online surveys, personal interviews, and telephonic discussions to understand the market dynamics comprehensively.

    The following is a breakdown of the primary respondents:

    Pharmaceutical Excipients Market

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both bottom-up and top-down approaches were used to estimate and validate the total size of the Pharmaceutical Excipients market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • A list of the major global players operating in the pharmaceutical excipients market was generated.
    • The revenues generated from their pharmaceutical excipients product have been determined through annual reports and secondary sources.
    • The products were mapped according to the segments of the market. Percentage shares and splits were determined based on the revenue contributed to each segment. This was verified using secondary sources and by industry experts.
    • All assumptions, approaches, and individual shares/revenue estimates were validated through expert interviews.

    Global Pharmaceutical Excipients Market Size: Bottom-up and Top-down Approach

    Pharmaceutical Excipients Market

    Data Triangulation

    After arriving at the market size from the estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Pharmaceutical excipients are inactive substances added to medications alongside the active pharmaceutical ingredient (API). They serve various purposes, such as improving the drug's stability, bioavailability, delivery, and overall effectiveness. These components, including preservatives, binders, fillers, disintegrants, lubricants, and flavoring agents, contribute to the final drug product's quality and efficacy.

    Stakeholders

    • Manufacturers, Importers & Exporters, Traders, Distributors, and Suppliers of Pharmaceutical Excipients
    • Pharmaceutical and Biopharmaceutical Companies
    • Distributors and Suppliers of Pharmaceutical Excipients
    • Contract Manufacturing Organizations (CMOs)
    • Suppliers and Distributors of Pharmaceutical Products
    • Research & Development (R&D) Companies
    • Pharmaceutical/Medical Associations
    • Regulatory Bodies & Government Agencies
    • Research Institutes and Government Organizations
    • Venture Capitalists and Investors
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms

    Report Objectives

    • To define, describe, and forecast the pharmaceutical excipients market based on product, functionality, formulation, functionality applications, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the pharmaceutical excipients market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments concerning six main regions—North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global pharmaceutical excipients market and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product approvals and launches, expansions, agreements, and collaborations in the pharmaceutical excipients market
    • To benchmark players within the pharmaceutical excipients market using the company evaluation matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

     

    Get the Full Pharmaceutical Excipients Market Report

    Full forecast, segment splits, and company analysis for all Pharmaceutical Excipients Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status